Correction: Acral Melanoma in Skin of Color: Current Insights and Future Directions: A Narrative Review (Cancers, (2025), 17, 3, (468), 10.3390/cancers17030468)

In the published publication [1], one affiliation was missing. The corrected list now includes a total of four affiliations. The correct Affiliations 1, 3, and 4 are provided below: Department of Dermatology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; [email protected] (E.R.N.); [email protected] (T.R.Z.); [email protected] (B.N.M.) Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA; [email protected] (M.A.); [email protected] (K.K.); [email protected] (M.L.); [email protected] (A.S.); [email protected] (K.L.T.); [email protected] (J.Y.) Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA; [email protected] There was an error in the original publication [1] regarding the heading sequence in the Abstract. A correction has been made to the Abstract section as follows: Abstract: Introduction: Acral lentiginous melanoma (ALM), a rare subtype, accounts for 2–3% of melanoma cases, primarily affecting the palms, soles, and nail beds and disproportionately affects people of color. This review focuses on clinical insights into ALM and its management, with a focus on race and ethnicity. Methods: A comprehensive literature search was conducted in public databases using the search term “acral melanoma,” and studies focusing on epidemiology, clinical presentation, and treatment outcomes of ALM in various racial and ethnic groups were reviewed. Results: Significant disparities in ALM outcomes exist across racial and ethnic groups, with African, Hispanic, and Asian individuals presenting with thicker, more advanced tumors at diagnosis. These populations encounter unique challenges, including limited access to dermatologic care, under-recognition of melanoma presentation in darker skin types, and socioeconomic barriers leading to delayed diagnosis and treatment. Surgical management may require specialized approaches, such as partial amputation for subungual melanomas. Additionally, there is uncertainty regarding the tumor immune microenvironment (TME) in ALM, with some studies suggesting that it might be less favorable, resulting in a lower response to immunotherapy. Conclusions: ALM affects diverse populations, and the impact of ethnic and racial origin on ALM biology is largely unknown. Addressing disparities in ALM outcomes among racial and ethnic groups is critical for improving patient care. Increased awareness of melanoma risk in individuals with darker skin can significantly impact early detection and treatment. Future research should focus on the genetic and biological factors contributing to morbidity and mortality in ALM patients. There was an error in the original publication [1] due to a grammatical mistake.